H.R.3492 — Protect Children’s Innocence Act
House Roll Call
H.R.3492
| Bill | H.R.3492 — Protect Children’s Innocence Act |
|---|---|
| Vote question | On Motion to Recommit |
| Vote type | Yea-and-Nay |
| Result | Failed |
| Totals | Yea 210 / Nay 218 / Present 0 / Not Voting 5 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 0 | 218 | 0 | 2 |
| D | 210 | 0 | 0 | 3 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Motion to Recommit
Bill Analysis
Bill Summary: HR 3492 - Protect Children’s Innocence Act
The Protect Children’s Innocence Act (HR 3492) aims to prohibit certain medical procedures and treatments for minors related to gender transition. Specifically, the bill seeks to prevent healthcare providers from administering puberty blockers, hormone therapies, or surgical interventions to individuals under the age of 18 for the purpose of gender transition.
Funding/Authorities: The bill does not allocate specific funding but establishes prohibitions that would affect the practices of healthcare providers and institutions that receive federal funds. It emphasizes the need for adherence to these regulations by healthcare professionals and facilities, potentially impacting their eligibility for federal funding if they do not comply.
Programs or Agencies Affected: The legislation primarily impacts healthcare providers, hospitals, and clinics that offer gender-affirming care. It also influences state and federal health programs, including Medicaid, by imposing restrictions on the types of treatments that can be covered for minors.
Beneficiaries and Regulation: The bill is designed to protect minors by restricting access to medical interventions that proponents argue may have irreversible effects on youth. It targets healthcare practices related to gender identity and aims to regulate the medical community’s approach to treating gender dysphoria in children and adolescents.
Key Timelines: As of the latest action, the bill has been placed on the Union Calendar, indicating it is scheduled for consideration by the House of Representatives. The timeline for further legislative action, including debates, amendments, and voting, has yet to be established. The bill’s progress will be closely monitored as it moves through the legislative process.
In summary, HR 3492 seeks to restrict gender transition-related medical interventions for minors, affecting healthcare practices and potentially reshaping the landscape of youth healthcare regarding gender identity in the U.S.
Yea (210)
J
Jason Crow
L
Lloyd Doggett
J
John Garamendi
J
John Mannion
R
Rashida Tlaib
N
Nydia Velázquez
D
Debbie Wasserman Schultz
Nay (218)
K
Ken Calvert
S
Scott Franklin
L
Lisa McClain
J
John Rutherford
D
David Schweikert
P
Pete Sessions
